EUVIMEDEUVIMED entdecken
Crossref

Minimal Clinically Important Difference for PROMIS Sleep Disturbance After Osteoid Osteoma Treatment

Semih Yaş, Asim Ahmadov, Buğra Türkoğlu, Resul Bircan, İbrahim Kaya, İsmail Burak Atalay, Coşkun Ulucaköy

Harran Üniversitesi Tıp Fakültesi Dergisi · 13.11.2026 · (Advanced Online Publication)

DOI: 10.35440/hutfd.1992356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Harran Üniversitesi Tıp Fakültesi Dergisi, online erschienen am 13.11.2026. Verfasst von Semih Yaş und 6 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Osteoid osteoma causes intense nocturnal pain that severely disrupts sleep. Although pain relief after definitive treatment is well known, the magnitude and clinical meaningfulness of sleep improvement remain unquantified. We aimed to establish disease-specific patient-reported benchmarks for sleep recovery after treatment for osteoid osteoma.Materials and Methods: Retrospective analysis of a prospectively maintained database with a prospective follow-up component for anchor-based analysis. Twenty-seven patients (median age, 22 years) treated surgically or with radiofrequency ablation were assessed using the PROMIS Sleep Disturbance Short Form 8b at baseline, 6 months, and 12 months. Longitudinal change was analyzed via a linear mixed-effects model, and anchor-based receiver operating characteristic (ROC) analysis was used to determine MCID, SCB, and PASS thresholds.

Results

Median PROMIS T-scores improved from 63.7 (IQR 62.6-64.9) preoperatively to 28.9 (IQR 28.9-35.9) at 12 months (β=-0.61; p<0.001). The anchor-based MCID was a decrease ≥18.0 points, the SCB ≥28.1 points, and the PASS ≤47.4. Overall, 81.5% achieved at least MCID and 74% achieved SCB.

Conclusion

Definitive treatment yields profound and sustained improvement in sleep quality. These preliminary benchmarks, which require external validation in larger cohorts, reflect the near-total symptom resolution unique to this condition and highlight the need for disease-specific patient-reported outcome measures.

Zitieren

APA

Yaş, S., Ahmadov, A., Türkoğlu, B., Bircan, R., Kaya, İ., Atalay, İ. B., & Ulucaköy, C. (2026). Minimal Clinically Important Difference for PROMIS Sleep Disturbance After Osteoid Osteoma Treatment. Harran Üniversitesi Tıp Fakültesi Dergisi. https://doi.org/10.35440/hutfd.1992356

Vancouver

Yaş S, Ahmadov A, Türkoğlu B, Bircan R, Kaya İ, Atalay İB, et al. Minimal Clinically Important Difference for PROMIS Sleep Disturbance After Osteoid Osteoma Treatment. Harran Üniversitesi Tıp Fakültesi Dergisi. 2026. doi:10.35440/hutfd.1992356

BibTeX
@article{Ya2026,
  author = {Yaş, Semih and Ahmadov, Asim and Türkoğlu, Buğra and Bircan, Resul and Kaya, İbrahim and Atalay, İsmail Burak and Ulucaköy, Coşkun},
  title = {Minimal Clinically Important Difference for PROMIS Sleep Disturbance After Osteoid Osteoma Treatment},
  journal = {Harran Üniversitesi Tıp Fakültesi Dergisi},
  year = {2026},
  number = {Advanced Online Publication},
  doi = {10.35440/hutfd.1992356}
}
Kostenlos starten →